J. Rajec

Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients

P. Babál, S. Pastoreková, K. Kajo, 2016, Oncology letters.

Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.

M. Mego, M. Reckova, J. Obertová, 2009, Neoplasma.

Plasma Cytokines Correlated With Disease Characteristics, Progression‐Free Survival, and Overall Survival in Testicular Germ‐Cell Tumor Patients

D. Cholujová, M. Chovanec, M. Mego, 2017, Clinical genitourinary cancer.

Prognostic factors in patients with relapsed or primary refractory germ cell tumors.

M. Mego, J. Obertová, K. Rejlekova, 2009, Neoplasma.

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors

P. Babál, S. Pastoreková, K. Kajo, 2017, Oncology letters.

Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report.

O. Hes, M. Mego, J. Obertová, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of everolimus in refractory testicular germ cell tumors.

M. Chovanec, M. Mego, D. Světlovská, 2016, Urologic oncology.

Determination of efficacy of TIP combination (paclitaxel, ifosfamide, cisplatin) as first salvage therapy for patients with relapsed germ cell tumors in a poor prognosis group.

M. Mego, M. Reckova, J. Obertová, 2009, Journal of Clinical Oncology.

Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.

Michal Mego, M. Mego, J. Obertová, 2011, Breast.

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .